IN2014MN01101A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01101A
IN2014MN01101A IN1101MUN2014A IN2014MN01101A IN 2014MN01101 A IN2014MN01101 A IN 2014MN01101A IN 1101MUN2014 A IN1101MUN2014 A IN 1101MUN2014A IN 2014MN01101 A IN2014MN01101 A IN 2014MN01101A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Pavel Osten
Original Assignee
Cold Spring Harbor Lab An Education Corp Of The State Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Lab An Education Corp Of The State Of New York filed Critical Cold Spring Harbor Lab An Education Corp Of The State Of New York
Publication of IN2014MN01101A publication Critical patent/IN2014MN01101A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN1101MUN2014 2011-11-11 2014-06-04 IN2014MN01101A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161558877P 2011-11-11 2011-11-11
PCT/US2012/064440 WO2013071099A1 (fr) 2011-11-11 2012-11-09 Procédé de criblage de médicament et ses utilisations

Publications (1)

Publication Number Publication Date
IN2014MN01101A true IN2014MN01101A (fr) 2015-07-03

Family

ID=48290605

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1101MUN2014 IN2014MN01101A (fr) 2011-11-11 2014-06-04

Country Status (8)

Country Link
US (1) US20140297199A1 (fr)
EP (1) EP2777074A4 (fr)
JP (1) JP2015507470A (fr)
CN (1) CN104040719A (fr)
CA (1) CA2854469A1 (fr)
IN (1) IN2014MN01101A (fr)
MX (1) MX2014005710A (fr)
WO (1) WO2013071099A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751696A4 (fr) * 2004-05-06 2010-05-05 Univ California Procede et systeme d'alignement et de classification d'images
CN105555961B (zh) * 2013-07-29 2021-04-27 加利福尼亚大学董事会 具有动态变化刺激的实时反馈系统控制技术平台
EP3268715B1 (fr) 2015-03-11 2024-09-25 TissueVision, Inc. Système et méthodes de coloration et d'imagerie en série
CN104850864A (zh) * 2015-06-01 2015-08-19 深圳英智源智能系统有限公司 一种基于卷积神经网络的非监督图像识别方法
EP3510500A4 (fr) 2016-09-12 2020-05-20 Cornell University Systèmes et procédés de calcul pour améliorer la précision de prédictions de toxicité de médicament
CA3044426A1 (fr) 2016-11-18 2018-05-24 Tissuevision, Inc. Systeme et procedes automatises de capture, d'indexation et de stockage de sections de tissus
US10303961B1 (en) * 2017-04-13 2019-05-28 Zoox, Inc. Object detection and passenger notification
CN106990077A (zh) * 2017-06-15 2017-07-28 福建师范大学 一种基于多光子显微与微流控芯片技术的高通量筛选系统
EP3451190B1 (fr) 2017-09-04 2020-02-26 Sap Se Analyse à base de modèle dans une base de données relationnelle
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
JP6559850B1 (ja) * 2018-07-27 2019-08-14 Ｋａｒｙｄｏ ＴｈｅｒａｐｅｕｔｉＸ株式会社 ヒトにおける被験物質の作用を予測するための人工知能モデル
US11486950B2 (en) * 2018-08-01 2022-11-01 General Electric Company Systems and methods for automated graphical prescription with deep neural networks
JP6558786B1 (ja) * 2018-09-28 2019-08-14 学校法人東北工業大学 標的の特性の予測を行うための方法、コンピュータシステム、プログラム
EP3644228B1 (fr) * 2018-10-23 2024-08-14 The Chinese University Of Hong Kong Procédé et appareil de segmentation d'image cellulaire
KR102307479B1 (ko) * 2019-02-12 2021-09-30 단국대학교 천안캠퍼스 산학협력단 신경전달물질 기반의 뇌 지도 작성 방법 및 뇌 지도를 이용하는 용도
US20220113288A1 (en) * 2019-02-12 2022-04-14 Neurovis Inc. Neurotransmitter-based brain mapping method and use of brain map
CN109709129A (zh) * 2019-02-13 2019-05-03 李秀利 一种高通量筛选药物的磁共振成像方法
US11808760B1 (en) * 2019-02-14 2023-11-07 Curi Bio, Inc. System and methods for in vitro structural toxicity testing
AU2020224659A1 (en) * 2019-02-20 2021-09-23 Bluerock Therapeutics Lp Detecting cells of interest in large image datasets using artificial intelligence
CN110178757B (zh) * 2019-04-19 2021-08-27 广东医科大学附属医院 一种斑马鱼脑创伤模型及其制备方法和应用
WO2021030270A1 (fr) * 2019-08-13 2021-02-18 Sanofi Prédiction de réponses de patient à une substance chimique
EP4047607A4 (fr) * 2019-10-17 2022-12-07 Karydo Therapeutix, Inc. Modèle d'intelligence artificielle permettant de prévoir des indications pour des substances de test sur des êtres humains
CN110850070B (zh) * 2019-11-22 2021-06-01 北京大学 一种基于荧光标记转基因动物模型评价化学物质生殖发育毒性的方法
CN111061729B (zh) * 2019-11-29 2021-04-16 武汉大学 顾及粒度的矢量瓦片组织方法
US12241830B2 (en) * 2019-12-06 2025-03-04 Broad Institute, Inc. Living biosensors
CN111062346A (zh) * 2019-12-21 2020-04-24 电子科技大学 一种白细胞自动定位检测及分类识别系统及方法
US11461216B1 (en) 2020-05-18 2022-10-04 Vignet Incorporated Monitoring and improving data collection using digital health technology
US11605038B1 (en) 2020-05-18 2023-03-14 Vignet Incorporated Selecting digital health technology to achieve data collection compliance in clinical trials
CN111657861B (zh) * 2020-06-04 2022-02-25 浙江大学 基于双光子显微镜技术的溶栓药效评价方法
WO2023044336A1 (fr) * 2021-09-14 2023-03-23 Massachusetts Institute Of Technology Procédés et réactifs pour diagnostiquer un trouble bipolaire
WO2024168475A1 (fr) * 2023-02-13 2024-08-22 深圳先进技术研究院 Procédé et dispositif d'évaluation pour comparer les effets anti-anxiété de différents médicaments avec efficacité
CN116369275B (zh) * 2023-03-01 2025-03-28 山东师范大学 一种特异性操作生长抑素神经元动物模型的构建方法
US12226125B2 (en) 2023-06-26 2025-02-18 Conceivable Life Sciences Inc. Autonomous vitrification in an intelligent automated in vitro fertilization and intracytoplasmic sperm injection platform

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998704B2 (en) * 2002-03-07 2011-08-16 Carnegie Mellon University Methods for magnetic resonance imaging
US8952213B2 (en) * 2002-04-26 2015-02-10 The Board Of Trustees Of The Leland Stanford Junior University Neuronal activation in a transgenic model
US7372985B2 (en) * 2003-08-15 2008-05-13 Massachusetts Institute Of Technology Systems and methods for volumetric tissue scanning microscopy
CN101484806A (zh) * 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法

Also Published As

Publication number Publication date
US20140297199A1 (en) 2014-10-02
EP2777074A1 (fr) 2014-09-17
CN104040719A (zh) 2014-09-10
WO2013071099A1 (fr) 2013-05-16
EP2777074A4 (fr) 2015-08-19
CA2854469A1 (fr) 2013-05-16
MX2014005710A (es) 2015-03-09
JP2015507470A (ja) 2015-03-12

Similar Documents

Publication Publication Date Title
BR112013022641A2 (fr)
IN2014MN01101A (fr)
BR112013031251A2 (fr)
BR112013027245A2 (fr)
BR112013024383A2 (fr)
BR112013023185A2 (fr)
BR112013026905A2 (fr)
BR112013022995A2 (fr)
BR112013027830A2 (fr)
BR112013026744A2 (fr)
BR112013023927A2 (fr)
BR112013027452A2 (fr)
BR112013024365A2 (fr)
BR112013028733A2 (fr)
BR112013027121A2 (fr)
AP2016009466A0 (fr)
BR112013024588A2 (fr)
BR112013031556A2 (fr)
BR112013026790A2 (fr)
BR112013032368A2 (fr)
BR112013032380A2 (fr)
BR112013032377A2 (fr)
BR112013027836A2 (fr)
BR112013026895A2 (fr)
BR112013027761A2 (fr)